Plasma EGF levels predict cognitive decline in Parkinson's Disease

OBJECTIVE: Most people with Parkinson's disease (PD) eventually develop cognitive impairment (CI). However, neither the timing of onset nor the severity of cognitive symptoms can be accurately predicted. We sought plasma-based biomarkers for CI in PD. METHODS: A discovery cohort of 70 PD patien...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Chen-Plotkin, Alice S., Hu, William T., Siderowf, Andrew, Weintraub, Daniel, Gross, Rachel Goldmann, Hurtig, Howard I., Xie, Sharon X., Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., McCluskey, Leo, Elman, Lauren, Van Deerlin, Vivianna M., Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2010
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155276/
https://ncbi.nlm.nih.gov/pubmed/21520231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.22271
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk